CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 85 filers reported holding CYTOKINETICS INC in Q3 2014. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,502,519 | -11.7% | 51,002 | -2.2% | 0.01% | 0.0% |
| Q2 2023 | $1,701,949 | -5.1% | 52,175 | +2.4% | 0.01% | -13.3% |
| Q1 2023 | $1,793,141 | -33.3% | 50,956 | -13.2% | 0.02% | -37.5% |
| Q4 2022 | $2,690,183 | +54.0% | 58,712 | +62.9% | 0.02% | +50.0% |
| Q3 2022 | $1,747,000 | +697.7% | 36,042 | +283.0% | 0.02% | +1500.0% |
| Q1 2021 | $219,000 | -43.8% | 9,410 | -49.9% | 0.00% | -50.0% |
| Q4 2020 | $390,000 | -78.2% | 18,775 | -84.8% | 0.00% | -50.0% |
| Q3 2017 | $1,790,000 | +30.7% | 123,456 | +9.0% | 0.00% | 0.0% |
| Q2 2017 | $1,370,000 | +1531.0% | 113,255 | +543.2% | 0.00% | – |
| Q2 2014 | $84,000 | -50.6% | 17,607 | -1.6% | 0.00% | – |
| Q1 2014 | $170,000 | +107.3% | 17,897 | +41.6% | 0.00% | – |
| Q4 2013 | $82,000 | -1.2% | 12,635 | +15.5% | 0.00% | – |
| Q3 2013 | $83,000 | – | 10,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,260,836 | $54,752,000 | 9.31% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 118,102 | $1,518,000 | 1.14% |
| FORTALEZA ASSET MANAGEMENT INC/ | 20,560 | $264,000 | 0.53% |
| TFS CAPITAL LLC | 95,987 | $1,233,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 152,200 | $1,956,000 | 0.38% |
| Nine Chapters Capital Management LLC | 20,600 | $265,000 | 0.36% |
| Timpani Capital Management LLC | 67,551 | $868,000 | 0.35% |
| WASATCH ADVISORS LP | 1,492,698 | $19,181,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $29,836,000 | 0.26% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 208,781 | $2,682,000 | 0.19% |